SOCS3 and IRTyr-960 are reduced in pioglitazone-treated type 2 diabetic rats. For both A and B, data presented include whole retinal analyses of lean (Ctrl), lean + pioglitazone (Ctrl+pio), BBZDR/Wor obese (Diab), and BBZDR/Wor obese + pioglitazone (Diab+pio) animals. A, Western blot results for SOCS3; B, Western blot results for IRTyr-960. *, p < 0.05 versus control; #, p < 0.05 versus diabetic. Data are mean ± S.E. (error bars); n = 5 in all groups. A.U., arbitrary units.